Clinical trial
A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
NCT00834457 is registered in ClinicalTrials.gov with Parirenyatwa Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
- Lead sponsor
- Parirenyatwa Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- July 31, 2009
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aids-related kaposi's sarcoma